JeanMarie Guenot Providing Better Medical Services

JeanMarie Guenot is a well-known woman who as contributed to the medical industry. She has over 20 years of experience, she has constructed and renovated medical facilities therefore enabling patients to access better medical attendance fully. She got his a Ph.D from the University of California and also MBA from the University of Pennsylvania in the Wharton School. Mostly particular in health states deals with biotechnology and pharmaceuticals.

She started supervising SKS Ocular and SKS Ocular 1 as the first companies, she was in control of the issuing medicine enterprises and ocular medicine. She as well controlled the PDL BioPhama while serving as the vice president of the company therefore making the company develop rapidly. JeanMarie Guenot also served as a consultant of Hoffmann-La Roche and Shanghai in Basel.additionally she also controlled Biogen Idec which consisted of 3 areas of Phase 2 cancer and autoimmune sick patients.

Read more: Collaboration to Advance T-Cell Engagement Therapies

Due to her great job she had done she was awarded in the year 2005 with Bio Business Network Initiative. She also took part in business adventures including contributing in the PDL’s industrial and cost-effective trades mentioned on businesswire.com. Also she was an administrative member committee of the company and the executive team associate. Not only did she helped cancer patients but also he contributed in the eliminating other diseases including neurology, oncology and autoimmune diseases.

JeanMarie Guenot with her colleagues are in control of Amphivena Therapeutics that is situated in Francisco in California. It was started with the goals of eliminating various forms of blood cancer. Cancer is one of the dangerous diseases in the world, the company is certain that they can eliminate cancer so that people can live healthy without any stress. They have invented certainly improved therapy strategies in order to bring together the immune system of cancer patients therefore leading to the destruction of cancer cells.

The organization are sure that they will accomplish more with the new strategies of therapy and so far they have made antibody cure that assists in knowing when the cancer signs appear. The company also gains contribution from different medical organization in helping them attain medical facilities so that they can help cancer patients.

Source: https://www.crunchbase.com/person/jeanmarie-guenot